Immunohistochemical patterns of reactive microenvironment are associated with clinicobiologic behavior in follicular lymphoma patients

Journal of Clinical Oncology

Volumn 24, Issue 34, 2006, Pages 5350-5357

  Álvaro Naranjo, Tomás ^a   Lejeune, Marylène ^a   Salvadó, Maria Teresa ^a   Lopez, Carlos ^a   Jaén, Joaquín ^a   Bosch, Ramón ^a   Pons, Lluis E ^a  

^a HOSPITAL VERGE DE LA CINTA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CD123 ANTIGEN; CD57 ANTIGEN; CHLORDANE; CYCLOPHOSPHAMIDE; DOXORUBICIN; PREDNISONE; RITUXIMAB; TRANSCRIPTION FACTOR FOXP3; VINCRISTINE; ANTINEOPLASTIC AGENT;

ADULT; ARTICLE; BEHAVIOR; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; FOLLICULAR LYMPHOMA; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MACROPHAGE; MAJOR CLINICAL STUDY; MALE; MICROENVIRONMENT; MULTICENTER STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; REGULATORY T LYMPHOCYTE; T LYMPHOCYTE; CD4 CD8 RATIO; DISEASE FREE SURVIVAL; IMMUNOLOGY; INFLAMMATION; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL RATE; T LYMPHOCYTE SUBPOPULATION; TISSUE DISTRIBUTION;

ANTIGENS, CD57; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CD4-CD8 RATIO; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LYMPHOMA, FOLLICULAR; MACROPHAGES; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL RATE; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES; TISSUE DISTRIBUTION;

EID: 34247190110     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2006.06.4766     Document Type: Article

References (42)

1. de Jong D: Molecular pathogenesis of follicular lymphoma: A cross-talk of genetic and immunologic factors. J Clin Oncol 23:6358-6363, 2005
2. Bohen SP, Troyanskaya OG, Alter O, et al: Variation in gene expression patterns in follicular lymphoma and the response to rituximab. Proc Natl Acad Sci U S A 100:1926-1930, 2003
3. Dave SS, Wright G, Tan B, et al: Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells. N Engl J Med 351:2159-2169, 2004
4. Glas AM, Kersten MJ, Delahaye LJ, et al: Gene expression profiling in follicular lymphoma to assess clinical aggressiveness and to guide the choice of treatment. Blood 105:301-307, 2005
5. Farinha P, Masoudi H, Skinnider BF, et al: Analysis of multiple biomarkers shows that lymphoma-associated macrophage (LAM) content is an independent predictor of survival in follicular lymphoma (FL). Blood 106:2169-2174, 2005
6. Farinha P, Campo E, Banham A, et al: The architectural pattern of FOXP3+ T cells is an independent predictor of survival in patients with follicular lymphoma (FL). Presented at Annual Meeting of the United States and Canadian Academy of Pathology, Atlanta, GA, February 11-17, 2006
7. Harris NL, Jaffe ES, Diebold J, et al: World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting - Airlie House, Virginia, November 1997. J Clin Oncol 17:3835-3849, 1999
8. Feller AC, Diebold J: Histopathology of Nodal and Extranodal Non-Hodgkin's Lymphomas (Based on the WHO Classification). Berlin, Germany, Springer-Verlag, 2004, pp 53-67
9. Nathwani BN, Harris NL, Weisenburger D: Follicular lymphoma, in Jaffe ES HN, Stein H, Vardiman JWS (eds): Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, France, International Agency for Research on Cancer Press, 2001, pp 162-167
10. Solal-Celigny P, Roy P, Colombat P, et al: Follicular lymphoma international prognostic index. Blood 104:1258-1265, 2004
11. Garcia JF, Camacho FI, Morente M, et al: Hodgkin and Reed-Sternberg cells harbor alterations in the major tumor suppressor pathways and cell-cycle checkpoints: Analyses using tissue microarrays. Blood 101:681-689, 2003
12. Alvaro T, Lejeune M, Salvado MT, et al: Outcome in Hodgkin's lymphoma can be predicted from the presence of accompanying cytotoxic and regulatory T cells. Clin Cancer Res 11:1467-1473, 2005
13. Alvaro-Naranjo T, Lejeune M, Salvado-Usach MT, et al: Tumor-infiltrating cells as a prognostic factor in Hodgkin's lymphoma: A quantitative tissue microarray study in a large retrospective cohort of 267 patients. Leuk Lymphoma 46:1581-1591, 2005
14. Roncador G, Garcia JF, Maestre L, et al: FOXP3, a selective marker for a subset of adult T-cell leukaemia/lymphoma. Leukemia 19:2247-2253, 2005
15. Roncador G, Brown PJ, Maestre L, et al: Analysis of FOXP3 protein expression in human CD4+CD25+ regulatory T cells at the single-cell level. Eur J Immunol 35:1681-1691, 2005
16. Kuppers R: Prognosis in follicular lymphoma: It's in the microenvironment. N Engl J Med 351:2152-2153, 2004
17. Chang KC, Huang X, Medeiros LJ, et al: Germinal centre-like versus undifferentiated stromal immunophenotypes in follicular lymphoma. J Pathol 201:404-412, 2003
18. Thomazy VA, Vega F, Medeiros LJ, et al: Phenotypic modulation of the stromal reticular network in normal and neoplastic lymph nodes: Tissue transglutaminase reveals coordinate regulation of multiple cell types. Am J Pathol 163:165-174, 2003
19. Shiozawa E, Yamochi-Onizuka T, Yamochi T, et al: Disappearance of CD21-positive follicular dendritic cells preceding the transformation of follicular lymphoma: Immunohistological study of the transformation using CD21, p53, Ki-67, and P-glycoprotein. Pathol Res Pract 199:293-302, 2003
20. Umetsu DT, Esserman L, Donlon TA, et al: Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones. J Immunol 144:2550-2557, 1990
21. Dvoretsky P, Wood GS, Levy R, et al: T-lymphocyte subsets in follicular lymphomas compared with those in non-neoplastic lymph nodes and tonsils. Hum Pathol 13:618-625, 1982
22. Schmitter D, Koss M, Niederer E, et al: T-cell derived cytokines co-stimulate proliferation of CD40-activated germinal centre as well as follicular lymphoma cells. Hematol Oncol 15:197-207, 1997
23. Aarts WM, Bende RJ, Bossenbroek JG, et al: Variable heavy-chain gene analysis of follicular lymphomas: Subclone selection rather than clonal evolution over time. Blood 98:238-240, 2001
24. Aarts WM, Bende RJ, Vaandrager JW, et al: In situ analysis of the variable heavy chain gene of an IgM/IgG-expressing follicular lymphoma: Evidence for interfollicular trafficking of tumor cells. Am J Pathol 160:883-891, 2002
25. Dorfman DM, Schultze JL, Shahsafaei A, et al: In vivo expression of B7-1 and B7-2 by follicular lymphoma cells can prevent induction of T-cell anergy but is insufficient to induce significant T-cell proliferation. Blood 90:4297-4306, 1997
26. West KP, Potter LJ, Henderson SD, et al: A retrospective study of follicular lymphomas. Histopathology 14:629-636, 1989
27. Lim HW, Hillsamer P, Kim CH: Regulatory T cells can migrate to follicles upon T cell activation and suppress GC-Th cells and GC-Th cell-driven B cell responses. J Clin Invest 114:1640-1649, 2004
28. Kim JR, Lim HW, Kang SG, et al: Human CD57+ germinal center-T cells are the major helpers for GC-B cells and induce class switch recombination. BMC Immunol 6:1-12, 2005
29. Strickler JG, Copenhaver CM, Rojas VA, et al: Comparison of "host cell infiltrates" in patients with follicular lymphoma with and without spontaneous regression. Am J Clin Pathol 90:257-261, 1988
30. de Vos S, Hofmann WK, Grogan TM, et al: Gene expression profile of serial samples of transformed B-cell lymphomas. Lab Invest 83:271-285, 2003
31. Monti S, Savage KJ, Kutok JL, et al: Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response. Blood 105:1851-1861, 2005
32. Bouzahzah F, Bosseloir A, Heinen E, et al: Human germinal center CD4+CD57+ T cells act differently on B cells than do classical T-helper cells. Dev Immunol 4:189-197, 1995
33. Butch AW, Chung GH, Hoffmann JW, et al: Cytokine expression by germinal center cells. J Immunol 150:39-47, 1993
34. Toellner KM, Scheel-Toellner D, Sprenger R, et al: The human germinal centre cells, follicular dendritic cells and germinal centre T cells produce B cell-stimulating cytokines. Cytokine 7:344-354, 1995
35. Johansson-Lindbom B, Ingvarsson S, Borrebaeck CA: Germinal centers regulate human Th2 development. J Immunol 171:1657-1666, 2003
36. Jooss K, Gjata B, Danos O, et al: Regulatory function of in vivo anergized CD4(+) T cells. Proc Natl Acad Sci U S A 98:8738-8743, 2001
37. Anonymous: A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma. The Non-Hodgkin's Lymphoma Classification Project. Blood 89:3909-3918, 1997
38. Martin AR, Weisenburger DD, Chan WC, et al: Prognostic value of cellular proliferation and histologic grade in follicular lymphoma. Blood 85:3671-3678, 1995
39. Weisenburger D, Anderson J, Armitage J: Grading of follicular lymphoma: Diagnostic accuracy, reproducibility, and clinical relevance. Mod Pathol 11:142A, 1998 (abstr)
40. Oeschger S, Brauninger A, Kuppers R, et al: Tumor cell dissemination in follicular lymphoma. Blood 99:2192-2198, 2002
41. Su W, Spencer J, Wotherspoon AC: Relative distribution of tumour cells and reactive cells in follicular lymphoma. J Pathol 193:498-504, 2001
42. Winter JN, Gascoyne RD, Van Besien K: Low-grade lymphoma. Hematology Am Soc Hematol Educ Program 203-220, 2004